CORT: Corcept Therapeutics, Inc.
About
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Current Value
$54.311 Year Return
Current Value
$54.311 Year Return
Key Details
Market Cap
$5.69B
P/E Ratio
43.19
1Y Stock Return
113.63%
1Y Revenue Growth
39.67%
Dividend Yield
0.00%
Price to Book
8.9
Strategies that include CORT
Stock's related to CORT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AVXL | 53.71% | $698.71M | +22.62% | 0.00% |
| AGIO | 38.85% | $3.10B | +148.79% | 0.00% |
| DNLI | 38.55% | $3.50B | +33.66% | 0.00% |
| CARS | 36.10% | $1.20B | -2.01% | 0.00% |
| CUK | 35.86% | $3.29B | +77.76% | 0.00% |
| BIGC | 35.51% | $473.42M | -31.75% | 0.00% |
| WK | 35.11% | $5.00B | -3.95% | 0.00% |
| ZD | 34.55% | $2.37B | -14.73% | 0.00% |
| FARO | 33.82% | $486.17M | +40.51% | 0.00% |
| ARCT | 33.75% | $489.20M | -21.27% | 0.00% |
| ALRM | 33.39% | $2.95B | +3.34% | 0.00% |
| BL | 33.29% | $3.61B | +3.02% | 0.00% |
| OPEN | 32.59% | $1.14B | -31.62% | 0.00% |
| PDFS | 32.40% | $1.17B | -2.56% | 0.00% |
| INSM | 32.29% | $13.19B | +202.50% | 0.00% |
| HHH | 31.87% | $3.98B | +14.89% | 0.00% |
| RDFN | 31.75% | $1.01B | +24.16% | 0.00% |
| TXNM | 31.65% | $4.32B | +14.17% | 3.24% |
| PBPB | 31.40% | $293.68M | +4.36% | 0.00% |
| BCO | 31.33% | $4.00B | +19.00% | 1.04% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| FARM | 0.03% | $41.47M | -25.00% | 0.00% |
| MESO | -0.04% | $1.23B | +347.11% | 0.00% |
| UNH | 0.08% | $531.00B | +6.93% | 1.37% |
| VZ | 0.13% | $176.51B | +12.56% | 6.37% |
| JPM | 0.18% | $684.38B | +58.91% | 1.89% |
| BNTX | 0.18% | $25.51B | +9.51% | 0.00% |
| TXMD | 0.23% | $14.99M | -53.32% | 0.00% |
| SMMT | -0.24% | $14.74B | +910.10% | 0.00% |
| KDP | -0.33% | $42.76B | -1.22% | 2.77% |
| KMB | 0.34% | $45.22B | +11.57% | 3.58% |
| WBA | 0.34% | $7.17B | -60.49% | 12.19% |
| SMWB | 0.35% | $1.01B | +134.25% | 0.00% |
| CTLT | 0.38% | $10.69B | +47.79% | 0.00% |
| VRSK | -0.44% | $39.77B | +17.45% | 0.53% |
| XWDIX | -0.47% | - | - | 11.82% |
| KVUE | 0.48% | $45.42B | +19.05% | 3.43% |
| MET | -0.51% | $57.21B | +32.74% | 2.60% |
| NXTC | 0.56% | $36.69M | +6.50% | 0.00% |
| CAH | -0.56% | $28.64B | +12.14% | 1.70% |
| REYN | -0.57% | $5.79B | +3.76% | 3.35% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| OCX | -21.54% | $42.93M | -36.09% | 0.00% |
| DOGZ | -17.77% | $614.77M | +1,372.26% | 0.00% |
| NEUE | -15.06% | $40.93M | -34.13% | 0.00% |
| TEM | -15.06% | $8.50B | 0.00% | 0.00% |
| GIS | -14.01% | $34.85B | -2.91% | 3.78% |
| COR | -13.32% | $47.48B | +21.20% | 0.86% |
| CLX | -13.26% | $20.81B | +20.66% | 2.88% |
| WRB | -12.68% | $22.94B | +29.98% | 0.69% |
| TCTM | -12.31% | $8.10M | -42.99% | 0.00% |
| PULM | -11.69% | $19.83M | +202.98% | 0.00% |
| CPB | -11.25% | $12.96B | +7.08% | 3.40% |
| CSTE | -10.91% | $134.01M | +2.92% | 0.00% |
| CHD | -10.65% | $27.18B | +19.50% | 1.03% |
| OXBR | -10.30% | $19.05M | +178.18% | 0.00% |
| STG | -9.86% | $35.67M | +7.92% | 0.00% |
| PG | -9.57% | $402.15B | +14.14% | 2.33% |
| JNPR | -9.40% | $11.61B | +30.55% | 2.49% |
| APRE | -8.40% | $16.41M | -19.47% | 0.00% |
| TSN | -8.40% | $21.95B | +31.14% | 3.11% |
| KHC | -7.82% | $36.98B | -10.45% | 5.23% |
ETF's related to CORT
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -33.86% | $388.04M | 1.43% |
| UUP | -15.64% | $309.25M | 0.77% |
| VIXY | -15.32% | $195.31M | 0.85% |
| USDU | -13.83% | $201.97M | 0.5% |
| CTA | -11.43% | $350.27M | 0.78% |
| TAIL | -10.98% | $67.98M | 0.59% |
| EQLS | -7.95% | $76.08M | 1% |
| CLOI | -7.37% | $715.40M | 0.4% |
| UNG | -6.87% | $908.80M | 1.06% |
| BILZ | -5.57% | $563.02M | 0.14% |
| SGOV | -5.51% | $27.53B | 0.09% |
| CCOR | -5.47% | $109.04M | 1.18% |
| TBIL | -5.45% | $4.38B | 0.15% |
| IYK | -3.49% | $1.30B | 0.4% |
| GBIL | -2.86% | $5.60B | 0.12% |
| HDRO | -2.63% | $164.26M | 0.3% |
| MUST | -2.59% | $410.00M | 0.23% |
| XBIL | -1.47% | $637.70M | 0.15% |
| PWZ | -0.95% | $697.36M | 0.28% |
| FMF | -0.72% | $244.61M | 0.95% |
News
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 37.9% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SeekingAlpha
The fund posted returns of 8.88%Â (Institutional shares) and 8.79% (Investor A shares, without sales charge) for the third quarter of 2024.
SeekingAlpha
BlackRock Advantage Small Cap Growth Fund posted returns of 8.96% (I) for the third quarter of 2024. Click here to read the full commentary.
Yahoo
Investors target stocks that are witnessing a bull run. Some of the stocks seeing price strength are CDXC, SEZL, TILE, BGC, CORT.
Yahoo
Catalyst (CPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Yahoo
Investors should invest in CORT right now as the stock is doing extremely well in 2024 and its prospects look even brighter.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.